- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Abliva AB (ABLI)
Abliva AB stock price live, this page displays ST ABLI stock exchange data. View the ABLI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Abliva AB real time stock price chart below.
What Is the Abliva AB Stock Price Today?
The Abliva AB stock price today is 0.44.
What Is the Stock Symbol for Abliva AB?
The stock symbol for Abliva AB is ""ABLI.""
What Stock Exchange Does Abliva AB Trade On?
Abliva AB is listed and trades on the Stockholm stock exchange.
Is Abliva AB a Good Stock to Buy?
Determining whether Abliva AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ABLI quote. (ISIN: SE0002575340)
What Is the Abliva AB Stock Price Today?
The Abliva AB stock price today is 0.44.
What Is the Stock Symbol for Abliva AB?
The stock symbol for Abliva AB is ""ABLI.""
What Stock Exchange Does Abliva AB Trade On?
Abliva AB is listed and trades on the Stockholm stock exchange.
Is Abliva AB a Good Stock to Buy?
Determining whether Abliva AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ABLI quote. (ISIN: SE0002575340)
Stockholm
Currency in SEK
0.44
0.00(0.00%)
Closed·
Fair Value
An estimate of a Abliva AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.44
0.45
52 wk Range
0.11
0.46
Showing Abliva AB historical data. For real-time data please try another search
Fair Value
An estimate of a Abliva AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.440.45
52 wk Range
0.110.46
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ABLI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Abliva AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Currently not supported.
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Buy
Abliva AB Company Profile
Abliva AB (publ) discovers and develops medicines for the treatment of mitochondrial disease in Sweden. The company is developing KL1333 that is in Phase 2 clinical trial to treat chronic fatigue and myopathy in genetically confirmed adult patients with primary mitochondrial disease; and NV354, which has completed preclinical development for the treatment of mitochondrial disease with neurologic complications. It has a licensing and collaboration agreement with Owl Therapeutics for NeuroSTAT for the treatment of traumatic brain injury; and Yungjin Pharm on the clinical development of the KL1333, as well as Isomerase, Children’s Hospital of Philadelphia, Newcastle University and University College London, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden. As of February 7, 2025, Abliva AB (publ) operates as a subsidiary of Pharming Technologies B.V.
Compare ABLI to Peers and Sector
Metrics to compare | ABLI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipABLIPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −3.7x | −0.5x | |
PEG Ratio | 0.00 | −0.07 | 0.00 | |
Price/Book | 0.0x | 3.2x | 2.6x | |
Price / LTM Sales | 0.0x | 9.7x | 3.3x | |
Upside (Analyst Target) | 0.0% | 0.0% | 43.4% | |
Fair Value Upside | Unlock | 21.4% | 7.1% | Unlock |
Earnings
Latest Release
May 22, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.